{"database": "openregs", "table": "documents", "rows": [["FDA-2026-N-10606-0001", "FDA", "FDA-2026-N-10606", "Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public\nDocket; Request for Comments\u2014New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01%", "Notice", "Request for Comments", "2026-09-25T04:00:00Z", 2026, 9, "2026-09-25T04:00:00Z", "2026-10-30T03:59:59Z", "2026-10-15T09:00:38Z", "2026-19700", 1, 0, "09000064b95c540b"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-N-10606-0001"], "units": {}, "query_ms": 0.25707390159368515, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}